FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.1  |  FHIR Version n/a  User: [n/a]

20969011000001108: Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Aug 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
183901000001118 Oxylan 20mg modified-release tablets (Healthcare Pharma Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
183921000001113 Oxylan 20mg modified-release tablets (Healthcare Pharma Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2217041000001110 Oxylan 20mg modified-release tablets (G.L. Pharma UK Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2217051000001113 Oxylan 20mg modified-release tablets (G.L. Pharma UK Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2265621000001118 Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2265641000001111 Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2412871000001113 Oxylan 20mg modified-release tablets (Kent Pharma (UK) Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2412881000001110 Oxylan 20mg modified-release tablets (Kent Pharma (UK) Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
2631681000001110 Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2631691000001112 Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70079101000001118 Oxylan 20mg modified-release tablets (Chanelle Medical UK Ltd) (product) en Fully specified name Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
70079201000001113 Oxylan 20mg modified-release tablets (Chanelle Medical UK Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) Is a Oxycodone hydrochloride 20mg m/r tablet false Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) Has active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) Has manufactured dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) Has specific active ingredient Oxycodone hydrochloride true Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) Is a Oxylan true Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) Is a Oxycodone 20mg modified-release tablets false Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) Is a Oxycodone 20mg modified-release tablets true Inferred relationship Existential restriction modifier
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) 56 tablet 4 x 14 tablets Has AMP True Oxylan 20mg modified-release tablets (Gerot Lannach UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start